X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (23) 23
female (22) 22
index medicus (22) 22
male (22) 22
aged (18) 18
middle aged (17) 17
heart attacks (15) 15
cardiac & cardiovascular systems (14) 14
treatment outcome (12) 12
abridged index medicus (11) 11
cardiovascular (11) 11
mortality (11) 11
myocardial infarction (10) 10
percutaneous coronary intervention (10) 10
electrocardiography (9) 9
double-blind method (8) 8
heart attack (8) 8
myocardial infarction - drug therapy (8) 8
reperfusion (8) 8
internal medicine (7) 7
medicine, general & internal (7) 7
myocardial infarction - mortality (7) 7
thrombosis (7) 7
time factors (7) 7
myocardial infarction - diagnosis (6) 6
myocardial infarction - therapy (6) 6
platelet aggregation inhibitors - adverse effects (6) 6
studies (6) 6
therapy (6) 6
acute coronary syndromes (5) 5
adenosine - analogs & derivatives (5) 5
angioplasty, balloon, coronary (5) 5
anticoagulants (5) 5
cardiology (5) 5
drug therapy (5) 5
drug therapy, combination (5) 5
patients (5) 5
platelet aggregation inhibitors - therapeutic use (5) 5
prasugrel (5) 5
prospective studies (5) 5
risk factors (5) 5
trial (5) 5
adenosine - administration & dosage (4) 4
adult (4) 4
biomarkers (4) 4
cardiology and cardiovascular medicine (4) 4
cardiology and cardiovascular system (4) 4
care and treatment (4) 4
combined modality therapy (4) 4
confidence intervals (4) 4
drug dosages (4) 4
emergency medical services (4) 4
heart failure (4) 4
hemorrhage - chemically induced (4) 4
human health and pathology (4) 4
life sciences (4) 4
myocardial infarction - physiopathology (4) 4
outcomes (4) 4
platelet aggregation inhibitors - administration & dosage (4) 4
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (4) 4
purinergic p2y receptor antagonists - administration & dosage (4) 4
risk assessment (4) 4
survival analysis (4) 4
task-force (4) 4
thrombolysis (4) 4
acute myocardial infarction (3) 3
adenosine - adverse effects (3) 3
aldosterone (3) 3
angioplasty (3) 3
antibodies, monoclonal - adverse effects (3) 3
anticoagulants - administration & dosage (3) 3
anticoagulants - adverse effects (3) 3
anticoagulants - therapeutic use (3) 3
cardiopulmonary resuscitation (3) 3
clinical outcomes (3) 3
clinical trials (3) 3
clopidogrel (3) 3
coronary vessels (3) 3
corticosteroids (3) 3
double-blind (3) 3
dysfunction (3) 3
emergency medical services - methods (3) 3
eplerenone (3) 3
fibrinolytic agents - administration & dosage (3) 3
fibrinolytic agents - therapeutic use (3) 3
follow-up studies (3) 3
guidelines (3) 3
heart-failure (3) 3
hemorrhage (3) 3
immunoglobulin fab fragments - adverse effects (3) 3
inhibition (3) 3
intensive care (3) 3
management (3) 3
proportional hazards models (3) 3
spironolactone (3) 3
stents (3) 3
steroids (3) 3
ticagrelor (3) 3
transluminal angioplasty (3) 3
activation (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 07/2008, Volume 359, Issue 1, pp. 21 - 30
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9792, pp. 693 - 703
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2016, Volume 67, Issue 16, pp. 1917 - 1927
Background Mineralocorticoid receptor antagonists (MRA) improve outcome in the setting of post-myocardial infarction (MI) heart failure (HF). Objectives The... 
mortality | left ventricular dysfunction | mineralocorticoid receptor antagonists | CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-FAILURE | GUIDELINES | PREVENTS | OPERA | MINERALOCORTICOID RECEPTOR BLOCKADE | TASK-FORCE | SPIRONOLACTONE | DYSFUNCTION | OUTCOMES | EPLERENONE | Single-Blind Method | Myocardial Infarction - mortality | Age Factors | Follow-Up Studies | Spironolactone - administration & dosage | Humans | Middle Aged | Male | Ventricular Dysfunction, Left - mortality | Time Factors | Statistics, Nonparametric | Female | Heart Failure - diagnosis | Drug Therapy, Combination | Electrocardiography - methods | Heart Failure - mortality | Myocardial Infarction - diagnosis | Severity of Illness Index | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Ventricular Dysfunction, Left - diagnosis | Heart Failure - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | Myocardial Infarction - drug therapy | Ventricular Dysfunction, Left - drug therapy | Canrenoic Acid - administration & dosage | Sex Factors | Survival Analysis | Aged | Clinical trials | Corticosteroids | Aldosterone | Heart attack | Steroids | Studies | Confidence intervals | Heart failure | Cardiac arrhythmia | Plasma | Survival analysis | Heart attacks | Consent | Mortality | Electrocardiography | Potassium | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 11, pp. 1016 - 1027
This study compared administration of the antiplatelet agent ticagrelor in the ambulance with administration in the cath lab in patients with ST-segment... 
MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | GLYCOPROTEIN IIB/IIIA INHIBITORS | CLOPIDOGREL | MANAGEMENT | INITIATION | PLATELET INHIBITION | DOUBLE-BLIND | IIB-IIIA INHIBITORS | PRASUGREL | PRIMARY ANGIOPLASTY | Myocardial Infarction - mortality | Purinergic P2Y Receptor Antagonists - administration & dosage | Humans | Middle Aged | Male | Purinergic P2Y Receptor Antagonists - adverse effects | Adenosine - adverse effects | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Drug Therapy, Combination | Myocardial Infarction - diagnosis | Double-Blind Method | Time-to-Treatment | Anticoagulants - therapeutic use | Electrocardiography - drug effects | Adenosine - administration & dosage | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Coronary Angiography | Myocardial Infarction - drug therapy | Myocardial Reperfusion | Adenosine - analogs & derivatives | Aged | Hemorrhage - chemically induced | Emergency Medical Services | Administration | Care and treatment | Hospitals | Research | Management | Heart attack | Risk factors | Myocardial infarction | Heart attacks | Catheterization | Angiography | Clinical trials | Patients | Thrombosis | Thrombolysis | Bleeding | Clinical outcomes | Studies | Reperfusion | Blood platelets | Coronary vessels | Implants | Intubation | Acute coronary syndromes | Drug therapy | Index Medicus | Abridged Index Medicus | Infart de miocardi | Adenosine | Malalties coronàries | Anticoagulants (Medicine) | Anticoagulants (Medicina) | Adenosina | Coronary diseases | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
American Journal of Cardiovascular Drugs, ISSN 1175-3277, 4/2019, Volume 19, Issue 2, pp. 173 - 183
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 12/2014, Volume 64, Issue 24, pp. 2563 - 2571
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2001, Volume 344, Issue 25, pp. 1895 - 1903
Journal Article